Activity by Bob Nellis
The American Association of Physicists in Medicine (AAPM) has announced the election of Mayo Clinicâ€™s Stephen Riederer, Ph.D., as a Fellow of the association. The category of Fellow honors members who have distinguished themselves by their contributions in research, education or leadership in the medical physics community. The award was presented at the annual meeting of the AAPM in July.
Dr. Riederer has been the Director of the MR Laboratory and a member of the Physics Division of the Department of Radiology of Mayo Clinic in Rochester since 1988. His research interests are in the technical development of magnetic resonance imaging (MRI). This includes use of [...]
Mitochondrial disease has been one of the toughest conditions in medicine. ItÂ primarily impacts children inheriting the condition, leaving few if any treatment options. Today, a collaborative group of researchers -- including those from Mayo Clinic'sÂ Center forÂ Regenerative Medicine, report they have found a way to eliminate the fatal mutations the inherited DNA leaves in cells. The findings appear in the journal Nature.
This is a proof-of-concept study, but it paves the way toward the long search for a therapy.
The announcement from the Oregon University of Health & Science describes the breakthrough:
"The scientists successfully used mitochondrial replacement to create an [...]
Two Mayo Clinic psychiatrists have been recognized for their contributions to the study, diagnosis, and treatment of depression and bipolar disorder. Paul Croarkin, D.O., and Mark Frye, M.D., were both presented with the Depression and Bipolar Support Allianceâ€™s (DBSA) highest honors for members of the scientific community: Gerald L. Klerman Awards. The Klerman awards are named for the late Gerald L. Klerman, a psychiatrist and expert on depression.
Dr. Paul Croarkin is the Gerald L. Klerman Young Investigator Award recipient. Dr. Croarkin received his medical degree at the University of North Texas Health Science Center at University of North Texas. [...]
That question is coming up here at BIO 2015 in Philadelphia. People have heard about Destination Medical Center, the long range economic development initiative underway in Rochester, MN. But at the center of the futuristic images on the TV screens here, is the picture of Discovery Square. It's more than an artist's conception says Jamie Rothe, who is representing DMC at this international conference.
"It's both a physical location in the middle of Rochester and a virtual location," she explained. "Some of the visioning is still going on and we will have a pretty clear idea at the end of this year, but it's going to reflect the integration of science, technology, health [...]
The Philadelphia Convention Center is awash with devices, large and small molecules, bio-generators and an endless stream of technologies I canâ€™t hope to explain. Over 17,000 people are here to hear about the latest innovations, inventions, discoveries and ideas, but mostly they hope to make deals. Most American states and industrialized countries are here touting their technology strengths. Even some small island nations have booths declaring that they are â€śthe new biotech hub.â€ť BIO 2015 is essentially a trade show, but instead of cars or computers, the commodity is whatever can be commercialized from last yearâ€™s scientific discovery or engineering feat. Some outfits are toddlers in the business of science - start up companies with a [...]
At Mayo Clinic, the road to new treatments often begins in the laboratory. For over 100 years, Mayo scientists and physicians have worked together to advance care through medical science. That tradition of leadership by discovery is the Center for Biomedical Discovery. Established to sustain and grow Mayoâ€™s expertise and build on its foundation of discovery science, this strategic research center coordinates team-based investigation of the biological processes governing disease.
The center is directed by Mark McNiven, Ph.D., a veteran cell biology researcher who spent a decade as the chair of Mayoâ€™s Department of Biochemistry and Molecular Biology. Under his leadership, diverse teams of researchers are roadmapping disease to improve health. â€śOur center [...]
Sundeep Khosla, M.D., has been appointed to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) advisory council. The NIAMS advisory council is responsible for giving advice to the institute on policy issues as well as making recommendations for research proposals.
Dr. Khosla, director and principal investigator in the Mayo Clinic Center for Clinical and Translational Science (CCaTS) since 2013, is a former president of the American Society for Bone and Mineral Research. He also serves as the chair of the Governance Committee of the National Bone Health Alliance and is currently the dean for clinical and translational science at [...]
Treatment for HIV should begin right at the point of diagnosis. Thatâ€™s the conclusion of a major international clinical study funded by the National Institutes of Health. The Strategic Timing of AntiRetroviral Treatment (START) study is a randomized clinical trial operating on 215 sites in 35 countries, of which Mayo Clinic is one, funded by the National Institute of Health and conducted by the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT).
Mayo infectious disease specialist and HIV researcher Zelalem Temesgen, M.D., says this is the first clear-cut confirmation that U.S. treatment guidelines should become a global model in the [...]